Tuesday, 26 March 2019
Department of Health
Medicinal Products Reimbursement
696. To ask the Minister for Health the average time it takes to reimburse oncology medicines from initial application by the pharmaceutical company; the way in which this compares on a European average; and if he will make a statement on the matter. [13196/19]
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.